David represents business clients in all types of disputes, such as product liability (including pharmaceuticals and medical devices), toxic torts, medical and genetics negligence, breach of privacy, other personal injury claims, class actions, multidistrict litigation, governmental actions, insurance litigation, breaches of contract, allegations of fraud and unfair trade practices, commercial warranty disputes and intellectual property controversies.
His experience includes a wide variety of jury and non-jury trials, arbitrations, mediations and appeals. With a truly national practice, David has handled cases in state and federal courts in Massachusetts and throughout the country, including Rhode Island, Connecticut, Pennsylvania, Delaware, New York, New Jersey, Washington, DC, Maryland, Virginia, West Virginia, California, Washington, Illinois, Ohio, Michigan, Minnesota, Missouri, Kentucky, Mississippi, Texas, Iowa and Wyoming. He has also authored or supervised amicus briefs on important product liability, evidentiary, procedural and constitutional issues in a variety of courts, including more than twenty-five in the United States Supreme Court.
David has represented some of the world’s largest and most recognizable business enterprises, including Hoffmann-La Roche, Inc., Novartis Pharmaceuticals Corporation, Warner-Lambert Company, Pfizer Inc., Sanofi US, Genzyme Corporation, Otsuka America Pharmaceutical, Inc., Mylan Pharmaceuticals Inc., C.R. Bard, Inc., Becton Dickinson and Company, Laboratory Corporation of America Holdings, Brown & Williamson Tobacco Corporation, R.J. Reynolds Tobacco Company, Smith & Wesson Corp., Raytheon Corporation, Elf Atochem North America, Inc., BASF Corporation, Watts Water Technologies, Inc., Thomas & Betts Corporation, BIC Corporation, Lear-Siegler Diversified Holdings Corp., Amtrol Inc., General Dynamics Corporation, Reebok International Limited and John Hancock Life Insurance Company.